ZYME Q4 2020 Earnings — Zymeworks Inc. Revenue & Financial Results | Market Cap Arena

ZYMEZymeworks Inc.

$2B

Q4 2020 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$16M+735.4% YoY

Gross Profit

-$24M-153.6% margin

Operating Income

-$38M-239.4% margin

Net Income

-$38M-241.7% margin

EPS (Diluted)

$-0.74

QoQ Revenue Growth

+493.3%

Cash Flow

Operating Cash Flow

-$48M

Free Cash Flow

-$49M

Stock-Based Comp.

$6M

Balance Sheet

Total Assets

$538M

Total Liabilities

$128M

Stockholders' Equity

$410M

Cash & Equivalents

$242M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$16M	$2M	+735.4%
Gross Profit	-$24M	-$44M	+44.6%
Operating Income	-$38M	-$74M	+49.1%
Net Income	-$38M	-$72M	+47.5%

Revenue Segments

License and Service

$3M100%